Type 2 diabetes with foot ulcer risk - Nursing Case Study

Pathophysiology

• Primary mechanism: Insulin resistance occurs when cells in muscles, fat, and liver respond poorly to insulin, leading to elevated blood glucose levels. This is a central feature of Type 2 diabetes and contributes to vascular and nerve damage.

• Secondary mechanism: Hyperglycemia-induced microvascular damage impairs blood flow, particularly in the extremities, reducing the delivery of oxygen and nutrients essential for tissue repair and maintenance.

• Key complication: Peripheral neuropathy, resulting from chronic high blood glucose, causes loss of sensation in the feet, increasing the risk of unnoticed injuries and subsequent ulcer development.

Patient Profile

Demographics:

65-year-old female, retired school teacher

History:

• Key past medical history: Type 2 diabetes diagnosed 10 years ago, hypertension, hyperlipidemia

• Current medications: Metformin, Lisinopril, Atorvastatin, Insulin glargine

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Persistent foot pain and ulceration

• Key symptoms: Numbness and tingling in feet, frequent urination, increased thirst, fatigue

• Vital signs: Blood pressure 145/90 mmHg, Heart rate 88 bpm, Respiratory rate 18 breaths per minute, Temperature 98.6°F, Blood glucose 220 mg/dL

Section 1

Change in Patient Status:

As the clinical team continues to monitor the patient, they notice a significant change in the status of her foot ulcer. Over the past week, the ulcerated area on her left foot has not only failed to improve but has also increased in size and depth, now extending to the subcutaneous tissue. The wound bed appears pale and exudes a small amount of purulent discharge. The surrounding skin is erythematous and warm to the touch, indicative of possible infection. This change in the ulcer's condition raises concerns about the development of a more serious complication, such as cellulitis or osteomyelitis, particularly given the patient's compromised immune response due to poorly controlled diabetes.

Simultaneously, the patient's blood glucose levels have been persistently elevated, with readings consistently above 200 mg/dL despite adherence to her medication regimen. This hyperglycemia further exacerbates the risk of infection and delays healing. The patient's HbA1c levels, recently measured at 9.2%, highlight inadequate long-term glucose control, necessitating a reassessment of her current diabetes management plan. Additionally, the patient reports worsening numbness and tingling in her feet, which could signify progression of peripheral neuropathy, complicating her ability to perceive the extent of her foot injury.

Recognizing these developments, the healthcare team is prompted to take immediate action. They initiate a comprehensive wound care protocol, including debridement and more aggressive antibiotic therapy, while also coordinating with a diabetes educator to review and optimize the patient's insulin therapy and dietary management. This multifaceted approach aims to stabilize the patient's condition, prevent further complications, and improve overall quality of life. The team schedules follow-up appointments to closely monitor the ulcer's progress and adjust treatment as necessary, ensuring a proactive and patient-centered care plan.

Section 2

As the healthcare team implements the new interventions, they closely monitor the patient for any changes in her condition. During a follow-up visit, the initial assessment reveals that the erythema around the ulcer has slightly decreased, and the purulent discharge has reduced, indicating a potential positive response to the antibiotic therapy. However, the patient still reports significant discomfort and a persistent tingling sensation in her feet. Vital signs show a mild fever of 100.4°F, elevated heart rate at 96 bpm, and blood pressure slightly elevated at 142/88 mmHg, suggesting that while the infection may be responding to treatment, systemic inflammation is still present.

The team also reviews the latest laboratory results. The patient's white blood cell count, although slightly decreased from previous levels, remains elevated at 12,000/mm³, confirming ongoing infection. A recent MRI of the foot was performed to assess for osteomyelitis, revealing early signs of bone marrow edema, raising concerns for early-stage osteomyelitis. Based on these findings, the healthcare team discusses the possibility of altering the antibiotic regimen and considers consulting with an infectious disease specialist to tailor therapy more precisely.

As part of the holistic care approach, the diabetes educator reassesses the patient's insulin regimen and dietary habits. The patient's glucose levels have shown slight improvement, with consistent readings around 180 mg/dL, but the team recognizes the need for more aggressive glycemic control. The patient is educated on carbohydrate counting and the importance of maintaining consistent meal timing to prevent glucose fluctuations. The care team emphasizes the significance of ongoing monitoring and patient engagement in her treatment plan, facilitating her understanding of the connection between blood glucose control and wound healing. This tailored approach aims to not only address the current complications but also prevent future ones, setting the stage for the next steps in her care journey.

Section 3

During the subsequent visit, the healthcare team conducts a comprehensive assessment to evaluate the patient's response to the modified treatment plan and to identify any new complications. The erythema around the foot ulcer has further diminished, and the ulcer appears to be showing signs of granulation tissue, suggesting that the targeted antibiotic therapy may be effective. However, the patient now reports increased levels of fatigue and a new onset of malaise, raising concerns about her overall health status.

Vital signs reveal that the patient's fever persists at 100.6°F, and her heart rate has increased to 104 bpm. Blood pressure remains slightly elevated at 144/90 mmHg. These findings suggest that while local infection control is improving, systemic inflammation and possible infection progression may still be a concern. The team notes that despite slight improvements in glucose levels, with recent readings averaging 170 mg/dL, these levels remain suboptimal, potentially contributing to delayed healing and systemic stress.

To investigate further, a new set of laboratory tests is ordered, including comprehensive metabolic panel and inflammatory markers such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR). The results reveal an elevated CRP of 12 mg/L and an ESR of 30 mm/hr, indicating ongoing inflammation. The team discusses the possibility of additional imaging studies to assess the extent of osteomyelitis and considers the potential need for surgical intervention if conservative management fails. This situation underscores the importance of meticulous monitoring and the integration of multidisciplinary care to address the multifaceted challenges in managing this patient's diabetes and its complications, setting the stage for refining her treatment strategy further.

Section 4

The healthcare team, concerned about the patient's persistent fever and increased heart rate, decides to further investigate the potential for systemic complications, particularly the risk of osteomyelitis given the chronic nature of her foot ulcer. An MRI of the affected foot is ordered to provide detailed imaging of the bone and surrounding tissues. The imaging results reveal early signs of osteomyelitis in the metatarsal bones, a finding that necessitates a reevaluation of the current treatment plan. This diagnosis is pivotal, as it requires not only a continuation of aggressive antibiotic therapy but also a possible escalation to intravenous antibiotics to better penetrate the bone tissue.

In light of these findings, the healthcare team gathers to discuss the next steps. They emphasize the need for a multidisciplinary approach, involving infectious disease specialists, endocrinologists, and possibly a surgical consult to determine if debridement or other surgical interventions might be warranted. The team also revisits the patient's diabetic management, recognizing that tighter glycemic control is essential to support her immune response and promote healing. Adjustments to her insulin regimen are considered, along with dietary modifications and increased patient education on blood glucose monitoring.

As the patient is informed about the new diagnosis and the adjusted treatment plan, she expresses concerns about the potential for surgery and the impact on her daily life. The team provides reassurance, highlighting the importance of addressing the osteomyelitis promptly to prevent further complications. They also stress the role of proactive foot care and regular monitoring to prevent additional ulcers. This dialogue not only informs the patient but also empowers her to be an active participant in her care plan, setting the stage for ongoing collaboration and monitoring of her condition in the coming weeks.

Section 5

In the days following the adjustment to the patient's treatment plan, the healthcare team closely monitors her response to the interventions. The patient is started on intravenous antibiotics, specifically vancomycin and piperacillin-tazobactam, to target the osteomyelitis effectively. Initial lab results indicate a decrease in white blood cell count from 14,000/mm³ to 11,000/mm³, suggesting a positive response to the antibiotics. Her fever subsides slightly, now hovering around 100°F, and her heart rate stabilizes at 88 beats per minute. These changes are encouraging, yet the team remains vigilant for any signs of adverse reactions or complications.

However, during a routine assessment, the patient reports new-onset nausea and mild abdominal discomfort. Concerned about potential side effects from the intravenous antibiotics, the team orders a comprehensive metabolic panel and liver function tests. The results reveal mildly elevated liver enzymes, with ALT at 65 U/L and AST at 72 U/L, slightly above normal ranges. This prompts a reevaluation of her medication regimen. The healthcare team decides to continue monitoring her liver function closely while ensuring adequate hydration and nutritional support.

To address her ongoing concerns about maintaining her diabetes management amidst these complications, the endocrinologist collaborates with the nursing staff to refine her insulin regimen. Her hemoglobin A1c levels have decreased from 9.2% to 8.5%, indicating improved glycemic control. The patient receives additional education on carbohydrate counting and the importance of consistent blood glucose monitoring. She is encouraged by the progress and expresses a commitment to adhering to her revised care plan. The team's proactive approach and the patient's engagement are crucial to minimizing the risk of further complications and promoting healing.